ANN PATTERSON: Open Payments
NPI 1538701347 · SEWICKLEY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$810 in 33 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $810
Food & beverage: $810
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $188 |
| Novo Nordisk Inc | 4 | $93 |
| Ascendis Pharma Endocrinology Inc | 3 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $65 |
| Tandem Diabetes Care, Inc. | 3 | $60 |
| Lilly USA, LLC | 2 | $52 |
| Insulet Corporation | 2 | $52 |
| Madrigal Pharmaceuticals | 2 | $42 |
| Esperion Therapeutics, Inc. | 2 | $39 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
Products named: IMDELLTRA (AMG757), Yorvipath, Kerendia, REPATHA, t:slim X2 Insulin Pump with Control-IQ, MOUNJARO, Omnipod, Rybelsus.
Industry payments across PA — which companies pay providers there.
